Ligusticum chuanxiong: a chemical, pharmacological and clinical review
Yin Wang,
No information about this author
Liuyun Wu,
No information about this author
H. Wang
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 1, 2025
The
dried
rhizome
of
Ligusticum
chuanxiong
S.H.Qiu,
Y.Q.Zeng,
K.Y.Pan,
Y.C.Tang
and
J.M.Xu
(Apiaceae;
including
the
horticultural
variety
Hort.)
[synonym:
Conioselinum
anthriscoides
(H.Boissieu)
Pimenov
Kljuykov
(The
taxonomic
classification
has
been
adopted
by
World
Checklist
Vascular
Plants)]
is
a
traditional
Chinese
botanical
drug
renowned
for
its
anti-inflammatory
antioxidant
properties.
It
widely
used
to
treatment
various
diseases,
particularly
cardio-cerebral
vascular
diseases
(CCVDs).
This
review
aims
summarize
recent
advances
in
(CX)
research,
chemical
composition
pharmacological
effects,
modern
clinical
applications.
A
systematic
literature
search
was
conducted
using
keywords
such
as
"Chuanxiong,"
"traditional
medicine,"
"chemical
components,"
"metabolites,"
"CCVDs,"
"pharmacological
effects"
identify
relevant
published
between
2014
2025.
Databases
PubMed,
Web
Science,
Google
Scholar,
CNKI
were
utilized.
Chemical
structures
SMILES
format
retrieved
from
PubChem,
two-dimensional
generated
ChemDraw
Ultra
8.0.
Classical
prescriptions
obtained
authoritative
medicine
databases.
Over
100
metabolites
have
isolated
identified
CX,
classified
into
nine
major
classes.
Key
bioactive
compounds
include
senkyunolide
A,
ligustilide,
tetramethylpyrazine
(TMP),
ligusticum
CX
polysaccharides
(LCP).
demonstrates
significant
effects
treating
CCVDs,
atherosclerosis
(AS),
myocardial
cerebral
ischemia-reperfusion
injury,
hypertension.
Its
therapeutic
mechanisms
antiplatelet
activity,
endothelial
cell
protection,
anti-inflammatory,
antioxidant,
anti-apoptotic
can
be
administered
alone
or
combination
with
other
medicines
(TCMs)
drugs,
showing
efficacy
cardiovascular,
nervous
system,
digestive
system
disorders,
well
analgesia
anticancer
activities.
holds
substantial
value
multi-system
extensive
evidence
supporting
use
CCVDs.
Further
research
exploration
are
warranted
fully
harness
potential.
Language: Английский
Benzo[a]pyrene-Induced Developmental Toxicity in Caenorhabditis elegans: Potential Involvement of Insulin/IGF Signaling and Collagen Gene Dysregulation
Toxics,
Journal Year:
2025,
Volume and Issue:
13(5), P. 384 - 384
Published: May 9, 2025
Benzo[a]pyrene
(B[a]P)
is
a
widespread
and
persistent
organic
pollutant
that
poses
serious
threats
to
human
health.
Although
its
carcinogenic
properties
have
been
extensively
studied,
developmental
toxicity
underlying
mechanisms
remain
poorly
understood.
In
this
study,
we
employed
Caenorhabditis
elegans
(C.
elegans)
as
model
organism
investigate
the
effects
of
B[a]P
exposure
during
early
stages.
To
comprehensively
assess
B[a]P-induced
toxicity,
high-throughput
sequencing
along
with
transgenic
mutant
C.
strains.
Exposure
at
concentrations
exceeding
1
mg/L
significantly
reduced
larval
body
size,
decreased
number
adult
worms,
delayed
larval-to-adult
development.
Furthermore,
analyzed
expression
genes
involved
in
cuticle
collagen
synthesis
key
components
insulin/insulin-like
growth
factor
signaling
(IIS)
pathway,
including
daf-2
daf-16.
These
findings
suggest
may
be
associated
dysregulation
IIS
pathway.
Specifically,
appears
influence
activity
downstream
transcription
daf-16,
thereby
altering
collagen-related
genes.
This
disruption
contribute
development
impaired
maturation.
Our
study
provides
new
insights
into
environmental
hazards
reveals
potential
mechanism
toxicity.
Moreover,
our
highlight
critical
role
gene
regulation
serve
biomarkers
for
toxicant
exposure,
particularly
vulnerable
populations
such
children
undergoing
periods
Language: Английский